Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 15, Issue 3, 2005, Pages 174-180

  Martino, Francesco ^a   Martino, Eliana ^a   Morrone, Francesco ^a   Carnevali, Elisabetta ^a   Forcone, Roberta ^a   Niglio, Tarcisio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Children; Diet; Glucomannan; Plasma hypercholesterolemia

Indexed keywords

DIETHYLAMINOETHYLDEXTRAN; GELATIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANNAN;

ADOLESCENT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECT; EVALUATION AND FOLLOW UP; FEMALE; FIBER; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PLASMA; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; RISK; STATISTICAL ANALYSIS;

EID: 21644478591     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2004.04.004     Document Type: Article

References (35)

1. Istituto Nazionale di Statistica. Annuario statistico Italiano 2002. ISTAT; 2002.
2. McGill HC, McMahon A, Herderick EE, Malcom GT, Tracy RE, Strong JP. For the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 2000;72:1307S-15S.
3. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999;354:1234-41.
4. Pathological Determinants of Atherosclerotic in Youth (PDAY) Research Group. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Arterioscler Thromb 1993;13:1291-8.
5. Tracy RE, Newman III WP, Wattigney WA. Histological features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population: the Bogalusa Heart Study. Atherosclerosis 1995;116:163-79.
6. Berenson GS, Srinivasan S. Cholesterol as a risk factor for early atherosclerosis: the Bogalusa Heart Study. Prog Pediatr Cardiol 2003;17:113-22.
7. National Cholesterol Education Program (NCEP). Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:525-84.
8. American Academy of Pediatrics Committee on Nutrition. Cholesterol in childhood. Pediatrics 1998;101:141-7.
9. Vuksan V, Sievenpiper JL, Owen R, Swilley JA, Spadafora P, Jenkins DJ, et al. Beneficial effects of viscous dietary fiber from Konjac-Mannan in subjects with the insulin resistance syndrome. Diabetes Care 2000;23(1):9-14.
10. Jenkins DJA, Kendall CWC, Vuksan V. Viscous fibers, health claims, and strategies to reduce cardiovascular disease risk. Am J Clin Nutr 2000;71:401-2.
11. Haskell WL, Spiller GA, Jensen CD, Ellis BK, Gates JE. Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects. Am J Cardiol 1992;69(5):433-9.
12. Arvill A, Bodin L. Effect of short-term ingestion of kojac glucomannan on serum cholesterol in healthy men. Am J Clin Nutr 1995;61:585-9.
13. Chen HL, Sheu WH, Tai TS, Liaw YP, Chen YC. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects - a randomized double-blind trial. J Am Coll Nutr 2003;22(1):36-42.
14. Gallaher CM, Munion J, Hesslink Jr R, Wise J, Gallaher DD. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J Nutr 2000;130(11):2753-9.
15. Livieri C, Novanzi F, Lorini R. The use of highly purified glucomannan-based fibers in childhood obesity. Pediatr Med Chir 1992;14:195-8.
16. Societa Italiana d̀i Nutrizione Pediatrica. Raccomandazioni per la prevenzione in età pediatrica dell'aterosclerosi. Riv Ital Pediatr 2000;26:13-28.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of LDL-C concentration in plasma without the use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
18. BMPD Statistical Software, Inc. BMPD biomedical computer programs - PC version. Los Angeles: University of California Press; 1990.
19. Sanchez-Bayle M, Gonzales-Requejo A, Ascensio-Anton J, Ruiz-Jarabo C, Fernandez-Ruiz ML, Baeza J. The effect of fiber supplementation on lipid profile in children with hypercholesterolemia. Clin Pediatr 2001;40:291-4.
20. Zavoral JH, Hannan P, Fields DJ, Hanson MN, Frantz ID, Kuba K, et al. The hypolipidemic effect of locust bean gum food products in familial hypercholesterolemic adults and children. Am J Clin Nutr 1983;38:285-94.
21. Glassman M, Spark A, Berezin S, Schwarz S, Medow M, Newman LJ. Treatment of type IIa hyperlipidemia in childhood by a simplified American Heart Association diet and fiber supplementation. Am J Dis Child 1990;144:973-6.
22. Williams CL, Bollella M, Spark A, Puder D. Soluble fiber enhances the hypocholesterolemic effect of the step I diet in childhood. J Am Coll Nutr 1995;14:251-7.
23. Story JA, Kelley MS. Dietary fibre and lipoproteins. In: Vahouney GV, Kritchevsky D, editors. Dietary fibre in health and disease. New York and London: Plenum Press; 1982. p. 229-36.
24. Bosello O, Cominacini L, Zocca J, Garbin U, Ferrari F, Davoli A. Effects of guar gum on plasma lipoproteins and apoliporoteins C-II and C-III and patients affected by familial combined hyperlipoproteinemia. Am J Clin Nutr 1984;40:1165-74.
25. Vahouny GV, Kritchevsky D. Dietary fiber basic and clinical aspects. New York: Plenum Press; 1986.
26. Vahouny GV, Cassidy MM. Effects of dietary fiber on intestinal absorption of lipids. In: Spiller GA, editor. Handbook of dietary fiber in human nutrition. Boca Raton, FL: CRC Press; 1986.
27. Simpson HCR, Simpson RW, Lousley S. A high carbohydrate legominous fibre diet improves all aspects of diabetic control. Lancet 1981;1:1-5.
28. Schneeman BO. Dietary fiber and gastrointestinal function. Nutr Rev 1987;45:129-32.
29. Shuhachi K, Akiko E, Akira Y, Noboru S, Hideo S. Hypocholesterolemic activity and molecular weight of konjac mannan. Nutr Rep Int 1972;6(4):231-6.
30. Shuhachi K, Yuriko I, Akiko E, Akira Y. Effect of purification and cellulase treatment on the hypocholesterolemic activity of crude konjac mannan. J Nutr 1972;102:1689-98.
31. Zoppi G, Gobio Casali L, Deganello A. Potential complications in the use of wheat bran for constipation in infancy. J Pediatr Gastroenterol Nutr 1982;1:91-5.
32. Zoppi G. Le fibre vegetali nell'alimentazione del bambino. Minerva Pediatr 1980;32:1127-32.
33. Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983;67:730-4.
34. Vega-López S, Vidal-Quintanar RL, Fernandez ML. Sex and hormonal status influence plasma lipid responses to psyllium. Am J Clin Nutr 2001;74:435-41.
35. Vuksan V, Jenkins DJ, Spadafora P, Sievenpiper JL, Owen R, Vidgen E, et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. Diabetes Care 1999;22:913-9.